The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy

被引:61
|
作者
Kidoya, H. [1 ]
Kunii, N. [2 ,3 ]
Naito, H. [1 ]
Muramatsu, F. [1 ]
Okamoto, Y. [2 ]
Nakayama, T. [3 ]
Takakura, N. [1 ]
机构
[1] Osaka Univ, Res Inst Microbial Dis, Dept Signal Transduct, Suita, Osaka 5650871, Japan
[2] Chiba Univ, Grad Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, Chiba, Japan
[3] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan
基金
日本学术振兴会;
关键词
tumor angiogenesis; immune therapy; vascular normalization; vascular maturation; apelin/APJ; KILLER T-CELLS; V-ALPHA-14 NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; IN-VIVO; ENDOTHELIAL-CELLS; ANGIOGENIC FACTOR; BLOOD-VESSELS; APJ RECEPTOR; CANCER; ACTIVATION;
D O I
10.1038/onc.2011.489
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immature and unstable tumor vasculature provides an aberrant tumor microenvironment and leads to resistance of tumors to conventional therapy. Hence, normalization of tumor vessels has been reported to improve the effect of immuno-, chemo- and radiation therapy. However, the humoral factors, which can effectively induce maturation of tumor vasculature, have not been elucidated. In this study, we found that the novel peptide apelin and its receptor APJ can induce the morphological and functional maturation of blood vessels in tumors. This apelin-induced tumor vascular maturation enhances the efficacy of cancer dendritic cell-based immunotherapy and significantly suppresses tumor growth by promoting the infiltration of invariant natural killer T cells into the central region of the tumor and thereby robustly inducing apoptosis of tumor cells. Additionally, we showed APJ expression to be enhanced in the tumor endothelium in comparison with normal-state endothelial cells. These findings provide a new target for tumor vascular-specific maturation, which is expected to improve the efficacy of conventional cancer therapies. Oncogene (2012) 31, 3254-3264; doi:10.1038/onc.2011.489; published online 31 October 2011
引用
收藏
页码:3254 / 3264
页数:11
相关论文
共 50 条
  • [21] Breastmilk cell trafficking induces microchimerism-mediated immune system maturation in the infant
    Moles, Jean-Pierre
    Tuaillon, Edouard
    Kankasa, Chipepo
    Bedin, Anne-Sophie
    Nagot, Nicolas
    Marchant, Arnaud
    McDermid, Joann M.
    Van de Perre, Philippe
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2018, 29 (02) : 133 - 143
  • [22] High Dose Radiation Therapy (HDRT) Induces Notch1 Signaling in Endothelial Cells of Tumor Vasculature
    Banerjee, D.
    Grabham, P. W.
    Boboila, S.
    Barton, S. M.
    Yamashiro, D. J.
    Connolly, E. P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E653 - E653
  • [23] Ablation of EIF5A2 induces tumor vasculature remodeling and improves tumor response to chemotherapy via regulation of matrix metalloproteinase 2 expression
    Wang, Feng-Wei
    Cai, Mu-Yan
    Mai, Shi-Juan
    Chen, Jie-Wei
    Bai, Hai-Yan
    Li, Yan
    Liao, Yi-Ji
    Li, Chang-Peng
    Tian, Xiao-Peng
    Kung, Hsiang-Fu
    Guan, Xin-Yuan
    Xie, Dan
    ONCOTARGET, 2014, 5 (16) : 6716 - 6733
  • [24] Photodynamic therapy improves the clinical efficacy of advanced colorectal cancer and recruits immune cells into the tumor immune microenvironment
    Gu, Baohong
    Wang, Bofang
    Li, Xuemei
    Feng, Zedong
    Ma, Chenhui
    Gao, Lei
    Yu, Yang
    Zhang, Jing
    Zheng, Peng
    Wang, Yunpeng
    Li, Haiyuan
    Zhang, Tao
    Chen, Hao
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] Radiation therapy induces tumor-promoting immune suppression in the microenvironment of pancreatic carcinoma
    Tomkotter, Lena
    Werba, Gregor
    Nguy, Susanna
    Alothman, Sara
    Alqunaibit, Dalia
    Tiwari, Shaun
    Ly, Nancy Ngoc Giao
    Daley, Donnele
    Ochi, Atsuo
    Barilla, Rocky
    Torres-Hernandez, Alejandro
    Pellicciotta, Ilenia
    Du, Kevin
    Miller, George
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [26] Role of Apelin in Glioblastoma Vascularization and Invasion after Anti-VEGF Therapy: What is the Impact on the Immune System?
    Amoozgar, Zohreh
    Jain, Rakesh K.
    Duda, Dan G.
    CANCER RESEARCH, 2019, 79 (09) : 2104 - 2106
  • [27] Role of the Immune Component of Tumor Microenvironment in the Efficiency of Cancer Treatment: Perspectives for the Personalized Therapy
    Stakheyeva, Marina
    Riabov, Vladimir
    Mitrofanova, Irina
    Litviakov, Nikolai
    Choynzonov, Evgeny
    Cherdyntseva, Nadezhda
    Kzhyshkowska, Julia
    CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (32) : 4807 - 4826
  • [28] Cell therapy with surface-tethered IL-12 improves anti-tumor efficacy and activates the endogenous immune system
    Nardozzi, Jon
    Geretti, Elena
    Chang, De-Kuan
    McMillin, Douglas W.
    Lyons, Jesse
    Nielsen, Ulrik
    Andresen, Thomas
    Jones, Douglas
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Targeting Tumor Vasculature with TNF Leads Effector T Cells to the Tumor and Enhances Therapeutic Efficacy of Immune Checkpoint Blockers in Combination with Adoptive Cell Therapy
    Elia, Angela Rita
    Grioni, Matteo
    Basso, Veronica
    Curnis, Flavio
    Freschi, Massimo
    Corti, Angelo
    Mondino, Anna
    Bellone, Matteo
    CLINICAL CANCER RESEARCH, 2018, 24 (09) : 2171 - 2181
  • [30] ISTER (Immune System - Tumor Efficiency Rate): An important key for planning in radiotherapic facilities
    Sotolongo-Grau, O.
    Rodriguez-Perez, D.
    Santos-Miranda, J.A.
    Desco, M.M.
    Sotolongo-Costa, O.
    Antoranz, J.C.
    World Academy of Science, Engineering and Technology, 2010, 65 : 457 - 460